The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127162541 12716254 1 I 20160823 20160906 20160906 EXP CN-HQ SPECIALTY-CN-2016INT000866 INTERCHEM YANG S, LI S-Y, YU H, LI S, LIU W, LIU X, ET AL. METRONOMIC CHEMOTHERAPY WITH 5-FLUOROURACIL AND CISPLATIN FOR INOPERABLE MALIGNANT BOWEL OBSTRUCTION BECAUSE OF PERITONEAL DISSEMINATION FROM GASTRIC CANCER. CURR ONCOL. 2016;23(3):E248-E252 0.00 A Y 0.00000 20160906 MD CN CN

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127162541 12716254 1 PS CISPLATIN. CISPLATIN 1 Intravenous (not otherwise specified) 5 MG/M2, DAILY ON DAYS 1-4 AND 8-11, Q21 DAYS U 18057 5 MG/M**2
127162541 12716254 2 SS 5-FLUOROURACIL FLUOROURACIL 1 Intravenous (not otherwise specified) 300 MG/M2, DAILY ON DAYS1-5 AND 8-12, Q21 DAYS U 0 300 MG/M**2

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127162541 12716254 1 Malignant bowel obstruction
127162541 12716254 2 Malignant bowel obstruction

Outcome of event

Event ID CASEID OUTC COD
127162541 12716254 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127162541 12716254 Mucosal inflammation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found